Results 141 to 150 of about 29,324 (231)
#1614 Fenofibrates and chronic kidney disease – Is there anything to worry about? [PDF]
Maria Beatriz Bessa +3 more
openalex +1 more source
PPARα modulation of macrophage polarization and inflammatory signaling in mimic periodontitis. [PDF]
Arthur HU, Chen YY.
europepmc +1 more source
Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes. [PDF]
Şahin MF, Erol A, Bayrak G, Şahin A.
europepmc +1 more source
Upregulation of hepatic VLDLR via PPARα is required for the triglyceride-lowering effect of fenofibrate [PDF]
Yang Gao +5 more
openalex +1 more source
Diabetes and the Retina: The Role of Medical Treatment. [PDF]
Bloomgarden Z.
europepmc +1 more source
Innovative methods in evaluating the effects of lipid-lowering medication on bone tissue. [PDF]
Moldovan I +4 more
europepmc +1 more source
Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet [PDF]
Ying Han +7 more
openalex +1 more source

